EPA:NRX

Naturex Competitors

€134.40
0.00 (0.00 %)
(As of 09/12/2018)
Add
Compare
Today's Range
€134.40
Now: €134.40
€134.80
50-Day Range
€134.40
MA: €134.40
€134.40
52-Week Range N/A
Volume516 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Naturex (EPA:NRX) Vs. BEI, SAE, SZU, KWS, ZO1, and HBH

Should you be buying NRX stock or one of its competitors? Companies in the sector of "consumer defensive" are considered alternatives and competitors to Naturex, including Beiersdorf Aktiengesellschaft (BEI), Shop Apotheke Europe (SAE), Südzucker (SZU), KWS SAAT SE & Co. KGaA (KWS), zooplus (ZO1), and HORNBACH Holding AG & Co. KGaA (HBH).

Beiersdorf Aktiengesellschaft (ETR:BEI) and Naturex (EPA:NRX) are both consumer defensive companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings for Beiersdorf Aktiengesellschaft and Naturex, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Beiersdorf Aktiengesellschaft59301.88
Naturex0000N/A

Beiersdorf Aktiengesellschaft presently has a consensus price target of €97.00, indicating a potential upside of 5.23%. Given Beiersdorf Aktiengesellschaft's higher probable upside, research analysts plainly believe Beiersdorf Aktiengesellschaft is more favorable than Naturex.

Profitability

This table compares Beiersdorf Aktiengesellschaft and Naturex's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Beiersdorf AktiengesellschaftN/AN/AN/A
NaturexN/AN/AN/A

Valuation and Earnings

This table compares Beiersdorf Aktiengesellschaft and Naturex's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beiersdorf Aktiengesellschaft$7.02 billion2.98$560.02 million€2.4737.33
NaturexN/AN/AN/AN/AN/A

Beiersdorf Aktiengesellschaft has higher revenue and earnings than Naturex.

Summary

Beiersdorf Aktiengesellschaft beats Naturex on 3 of the 3 factors compared between the two stocks.

Naturex (EPA:NRX) and Shop Apotheke Europe (ETR:SAE) are both consumer defensive companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.

Valuation & Earnings

This table compares Naturex and Shop Apotheke Europe's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NaturexN/AN/AN/AN/AN/A
Shop Apotheke Europe$968.06 million3.39$-20,918,040.00(€1.17)-156.69

Naturex has higher earnings, but lower revenue than Shop Apotheke Europe.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Naturex and Shop Apotheke Europe, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Naturex0000N/A
Shop Apotheke Europe14702.50

Shop Apotheke Europe has a consensus price target of €199.75, suggesting a potential upside of 9.33%. Given Shop Apotheke Europe's higher possible upside, analysts plainly believe Shop Apotheke Europe is more favorable than Naturex.

Profitability

This table compares Naturex and Shop Apotheke Europe's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NaturexN/AN/AN/A
Shop Apotheke EuropeN/AN/AN/A

Summary

Shop Apotheke Europe beats Naturex on 3 of the 3 factors compared between the two stocks.

Naturex (EPA:NRX) and Südzucker (ETR:SZU) are both consumer defensive companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Naturex and Südzucker, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Naturex0000N/A
Südzucker04202.33

Südzucker has a consensus price target of €14.22, suggesting a potential upside of 5.57%. Given Südzucker's higher probable upside, analysts plainly believe Südzucker is more favorable than Naturex.

Earnings and Valuation

This table compares Naturex and Südzucker's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NaturexN/AN/AN/AN/AN/A
Südzucker$6.73 billion0.41$-149,474,400.00(€0.73)-18.40

Naturex has higher earnings, but lower revenue than Südzucker.

Profitability

This table compares Naturex and Südzucker's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NaturexN/AN/AN/A
SüdzuckerN/AN/AN/A

Summary

Südzucker beats Naturex on 3 of the 3 factors compared between the two stocks.

Naturex (EPA:NRX) and KWS SAAT SE & Co. KGaA (ETR:KWS) are both consumer defensive companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Valuation and Earnings

This table compares Naturex and KWS SAAT SE & Co. KGaA's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NaturexN/AN/AN/AN/AN/A
KWS SAAT SE & Co. KGaA$1.28 billion1.91$95.60 million€2.9025.51

KWS SAAT SE & Co. KGaA has higher revenue and earnings than Naturex.

Analyst Recommendations

This is a summary of recent ratings and target prices for Naturex and KWS SAAT SE & Co. KGaA, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Naturex0000N/A
KWS SAAT SE & Co. KGaA04002.00

KWS SAAT SE & Co. KGaA has a consensus target price of €70.67, suggesting a potential downside of 4.38%. Given KWS SAAT SE & Co. KGaA's higher probable upside, analysts plainly believe KWS SAAT SE & Co. KGaA is more favorable than Naturex.

Profitability

This table compares Naturex and KWS SAAT SE & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NaturexN/AN/AN/A
KWS SAAT SE & Co. KGaAN/AN/AN/A

Summary

KWS SAAT SE & Co. KGaA beats Naturex on 2 of the 2 factors compared between the two stocks.

Naturex (EPA:NRX) and zooplus (ETR:ZO1) are both consumer defensive companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Valuation and Earnings

This table compares Naturex and zooplus' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NaturexN/AN/AN/AN/AN/A
zooplus$1.81 billion1.04$18.87 million€2.6499.09

zooplus has higher revenue and earnings than Naturex.

Profitability

This table compares Naturex and zooplus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NaturexN/AN/AN/A
zooplusN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and target prices for Naturex and zooplus, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Naturex0000N/A
zooplus14202.14

zooplus has a consensus target price of €213.14, suggesting a potential downside of 18.52%. Given zooplus' higher probable upside, analysts plainly believe zooplus is more favorable than Naturex.

Summary

zooplus beats Naturex on 3 of the 3 factors compared between the two stocks.

Naturex (EPA:NRX) and HORNBACH Holding AG & Co. KGaA (ETR:HBH) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Valuation & Earnings

This table compares Naturex and HORNBACH Holding AG & Co. KGaA's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NaturexN/AN/AN/AN/AN/A
HORNBACH Holding AG & Co. KGaA$5.49 billion0.24$195.50 million€12.266.65

HORNBACH Holding AG & Co. KGaA has higher revenue and earnings than Naturex.

Profitability

This table compares Naturex and HORNBACH Holding AG & Co. KGaA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NaturexN/AN/AN/A
HORNBACH Holding AG & Co. KGaAN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Naturex and HORNBACH Holding AG & Co. KGaA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Naturex0000N/A
HORNBACH Holding AG & Co. KGaA00203.00

HORNBACH Holding AG & Co. KGaA has a consensus target price of €116.00, indicating a potential upside of 42.42%. Given HORNBACH Holding AG & Co. KGaA's higher possible upside, analysts clearly believe HORNBACH Holding AG & Co. KGaA is more favorable than Naturex.

Summary

HORNBACH Holding AG & Co. KGaA beats Naturex on 3 of the 3 factors compared between the two stocks.


Naturex Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Beiersdorf Aktiengesellschaft logo
BEI
Beiersdorf Aktiengesellschaft
0.7$92.18flat$20.91 billion$7.02 billion37.33
Shop Apotheke Europe logo
SAE
Shop Apotheke Europe
1.2$182.70flat$3.28 billion$968.06 million-156.69Analyst Report
Südzucker logo
SZU
Südzucker
0.9$13.47flat$2.75 billion$6.73 billion-18.40
KWS SAAT SE & Co. KGaA logo
KWS
KWS SAAT SE & Co. KGaA
0.8$73.90flat$2.44 billion$1.28 billion25.51News Coverage
zooplus logo
ZO1
zooplus
0.8$261.60flat$1.87 billion$1.81 billion99.09Analyst Report
HORNBACH Holding AG & Co. KGaA logo
HBH
HORNBACH Holding AG & Co. KGaA
2.0$81.45flat$1.30 billion$5.49 billion6.65
Metro logo
B4B3
Metro
1.5$10.30flat$30.65 million$24.42 billion6.26Analyst Report
News Coverage
Anheuser-Busch InBev SA/NV logo
ABI
Anheuser-Busch InBev SA/NV
0.5N/AN/A$0.00N/A0.00Analyst Report
Gap Down
Carrefour logo
CA
Carrefour
0.7$15.82flat$0.00N/A0.00Analyst Report
Danone logo
BN
Danone
0.8$59.68flat$0.00N/A0.00Analyst Report
Henkel AG & Co. KGaA logo
HEN3
Henkel AG & Co. KGaA
0.9$97.42flat$0.00N/A0.00High Trading Volume
Jerónimo Martins, SGPS logo
JMT
Jerónimo Martins, SGPS
0.4N/AN/A$0.00N/A0.00
L'Oréal logo
OR
L'Oréal
0.4$347.70flat$0.00N/A0.00
Pernod Ricard logo
RI
Pernod Ricard
0.9$175.30flat$0.00N/A0.00Analyst Report
News Coverage
This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.